Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing

Biological Psychiatry

Volumn 54, Issue 1, 2003, Pages 40-48

  Gallinat, Jürgen ^a   Bajbouj, Malek ^a   Sander, Thomas ^b   Schlattmann, Peter ^a   Xu, Ke ^c   Ferro, Erica F ^c   Goldman, David ^c   Winterer, Georg ^a,c,d  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

COMT genotype; Dopamine; P300; Prefrontal noise; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CARRIER; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0038433234     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01973-X     Document Type: Article

References (59)

1. Altshuler D., Daly M., Kruglyak L. Guilt by association. Nat Genet. 26:2000;135-137.
2. Baudena P., Halgren E., Heit G., Clarke J.M. Intracerebral potentials to rare target and distractor auditory and visual stimuli. III. Frontal cortex. Electroencephalogr Clin Neurophysiol. 94:1995;251-264.
3. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J., Duyn J., Coppola R., et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex. 10:2000;1078-1092.
4. Creutzfeldt O.D., Watanabe S., Lux H.D. Relations between EEG phenomena and potentials of single cortical cells. I. Evoked responses after thalamic and erpicortical stimulation. Electroencephalogr Clin Neurophysiol. 20:1966;1-18.
5. Daniel D.G., Berman K.F., Weinberger D.R. The effect of apomorphine on regional cerebral blood flow in schizophrenia. J Neuropsychiatry Clin Neurosci. 1:1989;377-384.
6. Daniel D.G., Weinberger D.R., Jones D.W., Zigun J.R., Coppola R., Handel S., et al. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci. 11:1991;1907-1917.
7. de Chaldee M., Laurent C., Thibaut F., Martinez M., Samolyk D., Petit M., et al. Linkage disequilibrium on the COMT gene in French schizophrenics and controls. Am J Med Genet. 88:1999;452-457.
8. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 98:2001;6917-6922.
9. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W. User's Guide for the SCID-I for DSM-IV Axis I Disorders - Research Version. 1996;Biometrics Research, New York.
10. Friedman D., Cycowicz Y.M., Gaeta H. The novelty P3 An event-related brain potential (ERP) sign of the brain's evaluation of novelty . Neurosci Biobehav Rev. 25:2001;355-373.
11. Frodl-Bauch T., Bottlender R., Hegerl U. Neurochemical substrates and neuroanatomical generators of the event-related P300. Neuropsychobiology. 40:1999;86-94.
12. Gallinat J., Riedel M., Juckel G., Sokullu S., Frodl T., Moukhtieva R., et al. P300 and symptom improvement in schizophrenia. Psychopharmacology (Berl). 158:2001;55-65.
13. Gallinat J., Mulert C., Bajbouj M., Herrmann W.M., Schunter J., Senkowski D., et al. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage. 17:2002;110-127.
14. Gallinat J, Senkowski D, Juckel G, Becker I, Sander T, Smolka M, et al (2002b): Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. NeuropsychopharmacologyOnline at http://www.acnp.org/sciweb/journal/toc.php, printed version in press.
15. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
16. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A. 95:1998;9991-9996.
17. Grossman M.H., Emanuel B.S., Budarf M.L. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics. 12:1992;822-825.
18. Halgren E., Marinkovic K., Chauvel P. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr Clin Neurophysiol. 106:1998;156-164.
19. Herken H., Erdal M.E. Catechol-O-methyltransferase gene polymorphism in schizophrenia Evidence for association between symptomatology and prognosis . Psychiatr Genet. 11:2001;105-109.
20. Horikawa Y., Oda N., Cox N.J., Li X., Orho-Melander M., Hara M., et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 26:2000;163-175.
21. Joober R., Gauthier J., Lal S., Bloom D., Lalonde P., Rouleau G., et al. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry. 59:2002;662-663.
22. Karayiorgou M., Altemus M., Galke B.L., Goldman D., Murphy D.L., Ott J., et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A. 94:1997;4572-4575.
23. Karoum F., Chrapusta S.J., Egan M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model . J Neurochem. 63:1994;972-979.
24. Kneavel M., Gogos J., Karayiorgou K., Luine V. Interaction of COMT gene deletion and environment on cognition. Soc Neurosci Abst. 26:2000;1-2.
25. Knight R.T., Scabini D., Woods D.L., Clayworth C.C. Contributions of temporal-parietal junction to the human auditory P3. Brain Res. 502:1989;109-116.
26. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics Description of a functional polymorphism and its potential application to neuropsychiatric disorders . Pharmacogenetics. 6:1996;243-250.
27. Lewis D.A., Campbell M.J., Foote S.L., Goldstein M., Morrison J.H. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci. 7:1987;279-290.
28. Li T., Ball D., Zhao J., Murray R.M., Liu X., Sham P.C., et al. Family-based linkage disequilibrium mapping using SNP marker haplotypes Application to a potential locus for schizophrenia at chromosome 22q11 . Mol Psychiatry. 5:2000;77-84.
29. Li T., Sham P.C., Vallada H., Xie T., Tang X., Murray R.M., et al. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet. 6:1996;131-133.
30. Liljequist R., Haapalinna A., Ahlander M., Li Y.H., Mannisto P.T. Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav Brain Res. 82:1997;195-202.
31. Logothetis N.K., Pauls J., Augath M., Trinath T., Oeltermann A. Neurophysiological investigation of the basis of the fMRI signal. Nature. 412:2001;150-157.
32. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase A revised mechanism and description of the thermolabile variant of the enzyme . Biochemistry. 34:1995;4202-4210.
33. Malhotra A.K., Kestler L.J., Mazzanti C., Bates J.A., Goldberg T., Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 159:2002;652-654.
34. Mattay V.S., Berman K.F., Ostrem J.L., Esposito G., Van Horn J.D., Bigelow L.B., et al. Dextroamphetamine enhances "neural network-specific" physiological signals A positron-emission tomography rCBF study . J Neurosci. 16:1996;4816-4822.
35. Mattay V.S., Callicott J.H., Bertolino A., Heaton I., Frank J.A., Coppola R., et al. Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage. 12:2000;268-275.
36. McLeod H.L., Fang L., Luo X., Scott E.P., Evans W.E. Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J Pharmacol Exp Ther. 270:1994;26-29.
37. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
38. Moldin S.O. Detection and replication of linkage to a complex human disease. Genet Epidemiol. 14:1997;1023-1028.
39. Norton N., Kirov G., Zammit S., Jones G., Jones S., Owen R., et al. Schizophrenia and functional polymorphisms in the MAOA and COMT genes No evidence for association or epistasis . Am J Med Genet. 114:2002;491-496.
40. Oades R.D., Halliday G.M. Ventral tegmental (A10) system Neurobiology. 1. Anatomy and connectivity . Brain Res. 434:1987;117-165.
41. Palmatier M.A., Kang A.M., Kidd K.K. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry. 46:1999;557-567.
42. Riley B.P., McGuffin P. Linkage and associated studies of schizophrenia. Am J Med Genet. 97:2000;23-44.
43. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
44. Robledo P., Kaneko W.M., Ehlers C.L. The effects of acute cocaine administration on auditory event-related potentials in rats. Neurosci Lett. 160:1993;4-8.
45. Rosa A., Zarzuela M., Cuesta M., Peralta V., Martinez-Larrea A., Serrano F., et al. New evidence for association between COMT gene and prefrontal neurocognitive functions in schizophrenia. Schizophr Res. 53:(suppl 1):2002;69.
46. Sawaguchi T. Catecholamine sensitivities of neurons related to a visual reaction time task in the monkey prefrontal cortex. J Neurophysiol. 58:1987;1100-1122.
47. Sawaguchi T., Matsumura M., Kubota K. Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex. Neurosci Res. 5:1988;465-473.
48. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci. 18:1998;2697-2708.
49. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.) The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 . J Clin Psychiatry. 59:(suppl 20):1998;22-33.
50. Steriade M., McCormick D.A., Sejnowski T.J. Thalamocortical oscillations in the sleeping and aroused brain. Science. 262:1993;679-685.
51. Turetsky B., Colbath E.A., Gur R.E. P300 subcomponent abnormalities in schizophrenia II. Longitudinal stability and relationship to symptom change . Biol Psychiatry. 43:1998;31-39.
52. Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry. 50:2001;825-844.
53. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics Catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase . Annu Rev Pharmacol Toxicol. 39:1999;19-52.
54. Weiss K.M., Terwilliger J.D. How many diseases does it take to map a gene with SNPs? Nat Genet. 26:2000;151-157.
55. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
56. Winterer G. Schizophrenia Reduced signal-to-noise ratio and impaired phase-locking during information processing . Biol Psychiatry. 51:(suppl):2002;445.
57. Winterer G., Mulert C., Mientus S., Gallinat J., Schlattmann P., Dorn H., et al. P300 and LORETA Comparison of normal subjects and schizophrenic patients . Brain Topogr. 13:2001;299-313.
58. Winterer G, Weinberger DR (2002): Cortical signal-to-noise ratio: Insight into the pathophysiology and genetics of schizophrenia. Clin Neurosci Res, in press.
59. Winterer G., Ziller M., Dorn H., Frick K., Mulert C., Wuebben Y., et al. Schizophrenia Reduced signal-to-noise ratio and impaired phase-locking during information processing . Clin Neurophysiol. 111:2000;837-849.